OLIVERA DESSIEUX: Open Payments
NPI 1831480573 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,802 in 86 payments from 16 companies in 2025. Trend: 2023 $1,586 · 2024 $1,542 · 2025 $1,802
Food & beverage: $1,725Education: $77
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $274 |
| ABBVIE INC. | 19 | $257 |
| Janssen Biotech, Inc. | 10 | $248 |
| Aimmune Therapeutics, Inc. | 10 | $220 |
| Ardelyx, Inc. | 10 | $207 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $102 |
| Regeneron Healthcare Solutions, Inc. | 4 | $84 |
| Gilead Sciences, Inc. | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
Products named: Wegovy, TREMFYA, ZENPEP, IBSRELA, RINVOQ, XIFAXAN, DUPIXENT, ENTYVIO.
Industry payments across TN — which companies pay providers there.
